SPRINGFIELD – A new measure sponsored by State Senator Mike Halpin that limits the cost of Epinephrine Auto-Injectors, commonly known by the brand name EpiPens, to a maximum of $60 per twin-pack was signed into law.

"We’re talking about something that is proven to save lives, and people aren’t able to afford it," said Halpin (D-Rock Island). "This law takes a swing at pharmaceutical companies who are lining their own pockets with profits on life saving medication. We are making EpiPens affordable and accessible for all residents of Illinois who require them."

Epinephrine Auto-Injectors are the only medication that works on the entire body to combat anaphylaxis, a potentially fatal allergic reaction. However, since 2017, a global shortage of these devices has made this medication increasingly difficult to obtain. Parts of the United States have experienced shortages since 2018, with the FDA permitting an extension of the recommended shelf life of EpiPens to combat the shortage.

In addition to the shortage, the cost of EpiPens has skyrocketed in recent years, with a twin pack costing anywhere from $500-700 on average, and a single injector costing anywhere from $300-400. This has placed a significant financial burden on families who need to keep multiple EpiPens on hand for emergencies.

“I want to personally thank Senator Halpin for championing this cause and sharing his platform, allowing me to lend my voice and advocacy in support of his efforts,” said Tiffany Mathis, CEO & Executive Director of the Boys & Girls Clubs of Central Illinois. “When my child’s life was on the line and I couldn’t afford the cost of EpiPens, it was the most helpless feeling I’ve ever felt as a mother; there was nothing I could do. I am so proud to know that with the passage of this bill, other parents won’t have to feel as helpless as I did, or have to choose between paying their bills and keeping their child alive.”

House Bill 3639 was signed into law on Friday and takes effect Jan. 1, 2025.